Download PDF
Thromb Haemost 2002; 88(04): 693-694
DOI: 10.1055/s-0037-1613281
Letters to the Editor
Schattauer GmbH

Angiotensin I Converting Enzyme, Angiotensin II Type 1 Receptor and Angiotensinogen Polymorphisms and Early Myocardial Infarction in Turkish Population

Cengiz Ermis
,
Micheal Y. Tsai
1   Department of Medicine, University of Minnesota, Department of Pediatric Molecular Pathology and Genetic
,
Naomi Q. Hanson
1   Department of Medicine, University of Minnesota, Department of Pediatric Molecular Pathology and Genetic
,
Nejat Akar
2   Department of Medicine, Medical School of Ankara University
,
Ömer Aras
1   Department of Medicine, University of Minnesota, Department of Pediatric Molecular Pathology and Genetic
› Author Affiliations
Further Information

Publication History

Received 24 May 2002

Accepted 28 May 2002

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E. et al. The genotype interactions of methylenetetrahydrofolate reductase and reninangiotensin system genes are associated with myocardial infarction. Atherosclerosis 1999; 145: 293-300.
    CrossrefPubMedGoogle Scholar
  • 2 Duncan JA, Scholey JW, Miller JA. Angiotensin II type receptor gene polymorphism in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 2001; 10: 111-6.
    CrossrefPubMedGoogle Scholar
  • 3 Thomas WG. Regulation of angiotensin II type 1 (AT1) receptor function. Regul Peptides 1999; 79: 9-23.
    CrossrefPubMedGoogle Scholar
  • 4 Chiu AT, Herblin WF, McCall DE. et al. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 165: 196-203.
    CrossrefPubMedGoogle Scholar
  • 5 Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A. et al. Synergistic effects of angiotensin converting enzyme and angiotensin II receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 334: 910-3.
    PubMedGoogle Scholar
  • 6 Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24 (01) 63-9.
    CrossrefPubMedGoogle Scholar
  • 7 Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993; 02 (05) 609-10.
    CrossrefPubMedGoogle Scholar
  • 8 Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S. et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
    CrossrefPubMedGoogle Scholar
  • 9 Akar N, Aras O, Omurlu K, Cin S. Deletion polymorphism at the angiotensin converting enzyme gene in Turkish patients with coronary artery disease. Scand J Clin Lab Invest 1998; 58: 491-6.
    CrossrefPubMedGoogle Scholar
  • 10 Nakauchi Y, Suehiro T, Yamamoto M, Yasuoka N, Arii K, Kumon Y, Hamashige N, Hashimoto K. Significance of angiotensin I converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary artery disease. Atherosclerosis 1996; 125: 161-9.
    CrossrefPubMedGoogle Scholar